General
Blood-clotting case in Australian AstraZeneca vaccine recipient being taken ‘very seriously’ by Therapeutic Goods Administration
Australia’s Acting Chief Medical Officer Michael Kidd has confirmed authorities are investigating a “probable” case of a rare clotting disorder in an Australian man who received the AstraZeneca vaccine.
Key points:
- It is not clear whether the clots are linked to the man receiving the vaccine
- The Therapeutic Goods Administration says there is no proven link between the AstraZeneca jab and blood clots
- The majority of Australians will receive a dose of the AstraZeneca vaccine, which is being manufactured in Melbourne
Professor Kidd said the matter was being taken “very seriously” and was being investigated by the Therapeutic Goods Administration (TGA).
The TGA’s vaccine safety investigation group will meet tomorrow and will seek to determine…
Continue Reading
-
General16 hours agoAmbulance response times sluggish despite Tasmanian ramping ‘ban’ promise
-
General22 hours agoEnergy chiefs say net zero ‘irreversible’ even though bills unlikely to fall ‘for a decade’
-
Business12 hours agoWhat it means for shareholders
-
Noosa News12 hours agoNew softball team swings into success